+Compare
LLY
Stock ticker: NYSE
AS OF
Loading...
Price
Loading...
Change
Loading...
Capitalization
516.84B

LLY Eli Lilly & Co Forecast, Technical & Fundamental Analysis

a manufacturer of pharmaceutical products

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I.Advisor
a Summary for LLY with price predictions
08:00 PM EDT Sep 28, 2023

LLY's RSI Indicator recovers from overbought zone

The 10-day RSI Indicator for LLY moved out of overbought territory on September 15, 2023. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 39 instances where the indicator moved out of the overbought zone. In of the 39 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 21, 2023. You may want to consider selling the stock, shorting the stock, or exploring put options on LLY as a result. In of 87 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for LLY turned negative on September 15, 2023. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LLY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

LLY broke above its upper Bollinger Band on September 07, 2023. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where LLY advanced for three days, in of 362 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 352 cases where LLY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 66, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. LLY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: LLY's P/B Ratio (46.729) is very high in comparison to the industry average of (6.035). LLY has a moderately high P/E Ratio (75.758) as compared to the industry average of (31.828). Projected Growth (PEG Ratio) (1.435) is also within normal values, averaging (3.311). LLY has a moderately low Dividend Yield (0.008) as compared to the industry average of (0.028). LLY's P/S Ratio (16.667) is very high in comparison to the industry average of (3.721).

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), ABBVIE (NYSE:ABBV), Merck & Co (NYSE:MRK), AstraZeneca PLC (NASDAQ:AZN), Pfizer (NYSE:PFE), Amgen (NASDAQ:AMGN), Bristol-Myers Squibb Co (NYSE:BMY), Gilead Sciences (NASDAQ:GILD), Biogen (NASDAQ:BIIB).

Industry description

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

Market Cap

The average market capitalization across the Pharmaceuticals: Major Industry is 79.84B. The market cap for tickers in the group ranges from 72.83K to 516.84B. LLY holds the highest valuation in this group at 516.84B. The lowest valued company is CRXTQ at 72.83K.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Major Industry was -1%. For the same Industry, the average monthly price growth was -4%, and the average quarterly price growth was -4%. CHGCY experienced the highest price growth at 8%, while SCLX experienced the biggest fall at -12%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Major Industry was 36%. For the same stocks of the Industry, the average monthly volume growth was 66% and the average quarterly volume growth was 18%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 28
P/E Growth Rating: 60
Price Growth Rating: 56
SMR Rating: 57
Profit Risk Rating: 66
Seasonality Score: -15 (-100 ... +100)
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I. Advisor
published Earnings

LLY is expected to report earnings to rise 36.49% to $2.88 per share on November 02

Eli Lilly & Co LLY Stock Earnings Reports
Q3'23
Est.
$2.88
Q2'23
Beat
by $0.13
Q1'23
Missed
by $0.07
Q4'22
Beat
by $0.29
Q3'22
Beat
by $0.07
The last earnings report on August 08 showed earnings per share of $2.11, beating the estimate of $1.98. With 933.11K shares outstanding, the current market capitalization sits at 516.84B.
A.I.Advisor
published Dividends

LLY paid dividends on September 08, 2023

Eli Lilly & Co LLY Stock Dividends
А dividend of $1.13 per share was paid with a record date of September 08, 2023, and an ex-dividend date of August 14, 2023. Read more...
A.I. Advisor
published General Information

General Information

a manufacturer of pharmaceutical products

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
Lilly Corporate Center
Phone
+1 317 276-2000
Employees
39000
Web
https://www.lilly.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MORF22.880.39
+1.73%
Morphic Holding
WDAY214.853.63
+1.72%
Workday
FSI2.720.04
+1.49%
Flexible Solutions International
IPAR134.26-1.23
-0.91%
Inter Parfums
PRTH3.24-0.04
-1.22%
Priority Technology Holdings

LLY and

Correlation & Price change

A.I.dvisor indicates that over the last year, LLY has been loosely correlated with BIIB. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if LLY jumps, then BIIB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LLY
1D Price
Change %
LLY100%
-1.34%
BIIB - LLY
50%
Loosely correlated
-0.30%
NVS - LLY
42%
Loosely correlated
-0.46%
MRK - LLY
42%
Loosely correlated
-1.29%
AMGN - LLY
40%
Loosely correlated
-0.76%
GILD - LLY
39%
Loosely correlated
-0.62%
More

Groups containing LLY

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LLY
1D Price
Change %
LLY100%
-1.34%
stable earnings
(undefined stocks)
45%
Loosely correlated
-1.02%
pharmaceuticals
(undefined stocks)
44%
Loosely correlated
-1.76%
Pharmaceuticals: Major
(undefined stocks)
37%
Loosely correlated
-0.38%
drugs
(undefined stocks)
34%
Loosely correlated
-2.65%
Pharmaceuticals
(undefined stocks)
0%
Poorly correlated
-0.55%